Read the full judgment text of HCA 1873/2013 on BabelCite. This High Court CFI judgment was delivered on 13 July 2016.
1. Genentech Inc. (“ Genentech ”) makes two applications under sections 102 and 103 of the Patents Ordinance, Cap.514 (“ the Ordinance ”) in respect of its Hong Kong Standard Patent No.1048260 (“ the Patent ”) titled “Dosages for Treatment with Anti-ErbB2 Antibodies”, the validity of which is under attack in these proceedings.
Cited by 1 case